Reduction of reperfusion injury with prostacyclin I2 after liver transplantation

Transplant Proc. 1999 Feb-Mar;31(1-2):1029-30. doi: 10.1016/s0041-1345(98)01888-0.

Authors

U P Neumann¹, U Kaisers, J M Langrehr, M Glanemann, A R Müller, M Lang, K P Platz, U Settmacher, T Steinmüller, W O Bechstein, P Neuhaus

Affiliation

¹ Chirurgische Klinik, Charité, Campus-Virchow, Humboldt-Universität zu Berlin, Germany.

PMID: 10083458
DOI: 10.1016/s0041-1345(98)01888-0

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Adult
Aspartate Aminotransferases / blood
Blood Transfusion
Epoprostenol / therapeutic use*
Female
Graft Survival / physiology*
Humans
Liver Transplantation / pathology
Liver Transplantation / physiology*
Male
Middle Aged
Receptors, Tumor Necrosis Factor / blood
Reperfusion Injury / prevention & control*

Substances

Receptors, Tumor Necrosis Factor
Epoprostenol
Aspartate Aminotransferases